// App-Quantinova.ai

2974 : Targeting CD38 inhibits metabolic capacity of acute myeloid leukemia in the tumour microenvironment

Researchers

Presenter

  • Jayna J. Mistry

Principal Investigators

  • Jamie A. Moore

  • Christopher R. Marlein

  • Charlotte Hellmich

  • Genevra Pillinger

  • Federica Di Palma

  • Angela Collins

  • Kristian M. Bowles

  • Stuart A. Rushworth

Medical Centers

  • Univeristy of East Anglia, United Kingdom

  • Earlham Institute, United Kingdom

  • Norfolk and Norwich University Hospitals NHS Trust, Norwich, United Kingdom.

  • Univeristy of East Anglia, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute myelocytic leukemia

  • Tuberculosis

  • Multiple Myeloma

Biomarkers

  • Cluster of Differentiation 34

  • Cluster of Differentiation 38

  • Translocator protein

Drug/Treatment

  • daratumumab Intravenous

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A